{
    "title": "103_s1249",
    "content": "The Act may be cited as the \"Tuberculosis Prevention and Control Amendments of 1993\". Between 10,000,000 and 15,000,000 people in the United States have been infected with tuberculosis, with nearly 26,000 new cases reported annually and over 1,700 deaths each year. The number of reported cases has increased from 22,201 in 1985 to 26,673 in 1992, with drug-resistant strains costing over $150,000 to treat and resulting in a high mortality rate. In 1992, tuberculosis cases were reported in all 50 states. In 1992, tuberculosis cases were reported in all 50 states, with drug-resistant strains costing over $150,000 to treat and resulting in a high mortality rate. Between 40 and 60 percent of patients receiving treatment die, and one third of the world's population harbors tuberculosis. It is still the number one killer among infectious diseases worldwide, with an estimated 8,000,000 new cases and 2,900,000 deaths each year. SEC. 3. PROGRAMS OF CENTERS FOR DISEASE CONTROL AND PREVENTION. The amendment to the Public Health Service Act allocates funding for tuberculosis prevention, control, and elimination programs for fiscal years 1994 to 1997. States applying for grants must submit a plan demonstrating how the funds will be used to provide tuberculosis services. The amendment to the Public Health Service Act allocates funding for tuberculosis prevention, control, and elimination programs. States applying for grants must submit a plan demonstrating how funds will be used to provide tuberculosis services to high-risk populations or areas with high infection rates. Plans must also show collaboration with other entities and use of funds for effective interventions. The amendment to the Public Health Service Act requires grant funds to be used for directly observed therapy or effective interventions for populations with high rates of tuberculosis infection. Additionally, the Secretary may conduct research and training to support these grants. The Secretary may conduct or support research and training for grants related to tuberculosis prevention and treatment. $26,000,000 is authorized for fiscal year 1994, with additional funding for subsequent years. A technical amendment removes a sentence from the Public Health Service Act. Research and research training regarding tuberculosis is to be conducted through the National Institute of Allergy and Infectious Diseases, with funding authorized for fiscal year 1994 and subsequent years. The Director of the Institute shall conduct basic research on tuberculosis, with $46,000,000 authorized for fiscal year 1994. Authorized appropriations of $46,000,000 for fiscal year 1994 and necessary sums for fiscal years 1995 through 1997 for research on tuberculosis through the National Institute on Allergy and Infectious Diseases. The Food, Drug and Cosmetic Act is amended to include a new section for tuberculosis drug and device research through the FDA. The Commissioner of Food and Drugs will implement a program to assist in developing tuberculosis protocols, review medical devices for tuberculosis diagnosis, and conduct research on drugs and devices for tuberculosis prevention. $5,000,000 is authorized for each fiscal year for this purpose."
}